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Abstract. The orientations of chiral quinuclidin-3-ol esters and benzoylcholine in the active site of horse 
butyrylcholinesterase have been investigated by flexible ligand docking. Change of the esters' acyl moiety 
as well as the substituent at the quinuclidinium nitrogen atom affected the activity and stereoselectivity of 
the biotransformations. Analysis of interactions in the active site revealed the most important binding pat-
terns for enantiomers, which define their reactivity. Calculated Gibbs energies of binding obtained by mo-
lecular docking simulations were well correlated to the experimentally determined binding affinities of the 
investigated chiral esters. (doi: 10.5562/cca2060) 
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INTRODUCTION 
Butyrylcholinesterase (BChE, EC 3.1.1.8, also called 
cholinesterase, pseudocholinesterase or nonspecific 
cholinesterase) is a nonspecific ester hydrolyzing en-
zyme with function in cholinergic neurotransmission 
and probably involved in some other nervous system 
activities.1 It is present in nearly all body fluids and 
tissues in vertebrates and can hydrolyze various esters 
of choline and other compounds, as well as some or-
ganophosphorus compounds. Furthermore, BChE was 
used in the prophylaxis of hazardous organophosphorus 
poisoning (pesticides, insecticides and chemical warfare 
agents).2 It is believed that BChE is involved in the 
pathological development of Alzheimer's disease and 
BChE inhibitors have been used to raise acetylcholine 
levels and accordingly delay symptoms of the illness.3 
Because of this and other significant pharmacological 
and toxicological functions it is important to understand 
and study interactions of small molecules in the active 
site of BChE.  
The specific structure of the active site of choli-
nesterases has been revealed by the resolved crystal 
structures.4,5 Like in other serine hydrolases, BChE 
catalysed hydrolysis is carried out by a catalytic triad 
Ser200, Glu327 and His440 in the active centre of the 
protein.6 The imidazole ring of histidine transfers pro-
tons between serine and glutamate. Initially, an en-
zyme–substrate complex is formed. An ester acyl–
enzyme intermediate is produced as a result of a nu-
cleophilic attack of the serine hydroxyl group on the 
acyl group. Finally, a water molecule deacylates the 
enzyme (Scheme 1). 
Derivatives of quinuclidin-3-ol are well known 
compounds with various pharmacological activities and 
are often the main or supportive part of the active sub-
stance.7,8 In our previous work,9,10 chiral esters of 
quinuclidin-3-ol and benzoylcholine were subjected to 
enzymatic hydrolysis in the presence of BChE11,12 and 
the kinetics of BChE-catalyzed hydrolyses were deter-
mined. The hydrolysis of quaternary quinuclidine esters 
proved to be highly enantioselective. Kinetic studies 
have shown that (R)-enantiomers of all tested quinu-
clidinium esters are to a large extent better substrates of 
the enzyme than (S)-enantiomers. On the other hand, 
(S)-enantiomers showed higher affinity toward BChE 
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cerning reactivity of enantiomers, we applied flexible 
ligand docking protocol, as implemented in AutoDock 
4.2.2.13 To determine structural characteristics of 
Michaelis complexes, 11 compounds (Figure 1) were 
docked into the active site of the homology structural 
model of BChE.14 
 
EXPERIMENTAL 
The coordinates of BChE were obtained from homology 
modeling.14 The enzyme was prepared for docking us-
ing the Autodock Tools15 (ADT). Polar hydrogens were 
added and a Gasteiger partial charge was assigned to 
each atom. 
Geometries of all ligands were optimized using 
the B3LYP functional16,17 and the 6-31G(d) basis set. 
All quantum chemical calculations were performed 
using the Gaussian 09 package.18 Non-polar hydrogens 
were removed from ligands and Gasteiger partial 
charges were assigned to all atoms using ADT. Tor-
sional motion around single bonds was allowed (Figure 
1). 
Docking studies were performed by using the 
AutoDock 4.2.2 suite of programs.13,19 AutoDock re-
quires a precalculated electrostatic grid map for each 
atom type present in the substrate molecule. These elec-
trostatic maps were calculated using the AutoGrid part 
of the suite with 0.2 Å spacing between grid points and 
 
Figure 2. BChE active site major domains a) esteratic site (blue labels), b) acyl pocket (green labels), c) choline subsite (red
labels), and d) the oxyanion hole (black labels). 
Figure 1. The ligands chosen for docking. Bonds where rota-
tion was allowed are highlighted with arrows. R and S letters 
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the centre of the grid was placed in the γ-oxygen atom 
of catalytic Ser200. Dimensions of the active site box 
were set to 20 Å × 20 Å × 20 Å thus ensuring appropri-
ate size of the ligand-accessible space. Consistencies of 
electrostatic maps were ascertained by checking maxi-
mum and minimum values of van der Waals energies 
and electrostatic potentials for each calculated grid map. 
Flexible ligand docking was performed for 10 new 
compounds (5 enantiomeric pairs) as well as for ben-
zoylcholine. Docking calculations were carried out 
using the Lamarckian genetic algorithm and all parame-
ters were the same for each docking run. We used ini-
tially a population of 5000 random individuals, a maxi-
mum number of 2×107 energy evaluations, a maximum 
number of generations of 1×106, elitism value of 1, 
mutation rate of 0.02 and crossover rate of 0.08. For the 
local search, the pseudo-Solis and Wets method was 
used with a maximum of 10000 iterations per local 
search, the probability of performing a local search on 
an individual in the same population was 0.06, the 
maximum number of consecutive successes or failures 
before changing the size of local search space was 4 in 
both cases, initial size of local search space to sample 
was 1.0 and its lower bound was 0.01. To ensure the 
validity of results, the docking procedure for each sub-
strate consisted of 100 independent docking runs. The 
resulting positions were clustered according to an r.m.s. 
criterion of 0.5 Å. Obtained structures were analyzed 
visually and evaluated based on their interactions with 
the amino acids within the active site of the enzyme. 
Table 1. Experimentaly determined Michaelis ( MK ) and 
inhibition ( iK ) constants
8,10,12 along with Gibbs energies of 





























1-R 0.28 – –20.62(a) –27.31 
1-S 0.13 – –22.55(a) –33.82 
2-R 0.127 – –22.61(a) –28.03 
2-S 0.065 – –24.30(a) –31.82 
3-R 0.023 – –26.92 (a) –35.82 
3-S – 3.3 –31.81(b) –40.88 
4-S – 12.3 –28.50(b) –37.52 
5-S – 60.5 –24.48(b) –35.44 
(a) Estimated as 1r b MlnG RT K
−∆ ≈ − . 
(b) Calculated as 1r b ilnG RT K
−∆ = − . 
 
Figure 3. Gibbs energies of binding r b,calcG∆
































ΔrG°b,exp / kJ mol−1
ΔrG°b,calc / kJ mol−1 = (1.15 ± 0.21)·ΔrG°b,exp / kJ mol−1 + (−4.8 ± 5.4)
R² = 0.8274
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RESULTS AND DISCUSSION 
In order to explain and rationalize experimentally ob-
tained data, enantiomers of five different qui-
nuclidinium esters (1–5) and benzoylcholine (BzCh) 
were docked into the active site of BChE by utilizing 
the AutoDock program. The BChE active site gorge14 
(Figure 2) consists of several major regions:  
a) esteratic site containing the active serine as a  
part of catalytic triad (Ser, His, Glu), b) acyl pocket - a 
hydrophobic region which accommodates the acyl 
group of an ester, c) choline subsite for the recognition 
of the substrate’s quaternary ammonium group and d) 
the oxyanion hole formed by the main chain  
 
Figure 4. Substrate-BChE complexes derived from docking study. BChE active site is represented by some structurally important
amino acids. Nonpolar hydrogen atoms are omitted for clarity. The entrance to the active site gorge is from below. (S)-enantiomer
(carbon atoms white), (R)-enantiomer (carbon atoms orange): A) BzCh, B) 1; C) 2; D) 3; E) 4; F) 5. Selected interatomic dis-
tances are given in Table 2. 
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Table 2. Selected interatomic distances between ligands and some important amino acids within the BChE active site (values not 
shown are greater than 8 Å ) 
Comp. 
(a )
Trp84(N – N )
Å














BzCh 4.570 3.249 3.183 2.631 
1-R 4.722 3.005 2.796 3.095 
1-S 6.159 – – – 
2-R 5.689 3.671 3.720 2.951 
2-S 5.766 – – – 
3-R 4.752 3.434 3.466 3.111 
3-S 3.948 6.228 3.667 6.032 
4-R 5.770 3.794 3.077 2.881 
4-S 4.977 – – – 
5-R 4.704 3.492 4.550 3.166 
5-S 4.955 – – – 
(a) From the ligand's quaternary N atom to the side chain Trp84 indole nitrogen atom. 
(b) From the ligand's carbonyl C atom to the side chain Ser200 γ-oxygen atom. 




Figure 5. Superimposed geometries of (S)-enantiomers: grey stick model (1), grey ball and stick model (2), white ball and stick 
model (3), yellow ball and stick model (4) and pale yellow stick model (5) obtained by docking simulations. Only amino acids 
having a close contact with the substrate's carboxyl oxygen atoms are presented (green lines). Nonpolar hydrogen atoms are omit-
ted for clarity. 
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N–H dipoles interacting with the carbonyl oxygen atom 
of the substrate. 
Several clusters of binding orientations for all sub-
strates were obtained. Since (S)-enantiomers were much 
better inhibitors than the substrates of the enzyme, clus-
ters with the lowest absolute energy values for (S)-
enantiomers were compared with the energies of the 
correctly placed geometries of (R)-enantiomers (rather 
good substrates) for the reaction to occur. The correct 
position for hydrolysis to occur was assumed to be the 
one with the acyl moiety in the acyl pocket and the ester 
carboxyl group in the vicinity of catalytic Ser hydroxyl 
group. In Table 1, the binding energies predicted by 
AutoDock in conjunction with the kinetic data compiled 
from the literature are shown. 
The calculated docking energies for quinuclidin-
ium esters were well correlated to the experimentally 
obtained values (R2=0.8274) as shown in Figure 3. Even 
better correlation is found within the series of only (R)-
enantiomers of compounds 1–3 (R2=0.9445) or only (S)-
enantiomers of compounds 1–5 (R2=0.8314). The good 
quantitative agreement between computed and experi-
mental values confirmed the correctness of the chosen 
docking method and analyses applied. 
Substrate-BChE complexes derived from docking 
studies for quinuclidinium compounds 1–5 and ben-
zoylcholine are shown in Figure 4. Analyses of the 
docked geometries for each pair of enantiomers re-
vealed trends in binding associated with the stereochem-
istry of substrates. (R)-enantiomers of all compounds 
and benzoylcholine are bound productively: the car-
bonyl group is found in the vicinity of hydroxyl oxygen 
atom of Ser200, forming two H-bonds with the back-
bone Gly118 and Gly119 amide group (Table 2). The 
quaternary quinuclidinium group of all enantiomers is 
positioned in the choline binding site and its orientation 
depends on the bulkiness of the substituents at the 
quinuclidinium nitrogen atom. Thus, compounds 1 and 
2 with the smallest substituents (protonated and methyl 
substituted (S)-quinuclidinium derivatives respectively) 
are bound in a similar way and are positioned in the 
vicinity of the Glu199 side chain: (a strong H-bond of 1-
S (2.6 Å) and 2-S (2.8 Å)). On the other hand, N-benzyl 
substituted compounds cannot have similar stabilization 
due to the present bulky aromatic moiety. Therefore, 
two different modes of binding for (S)-N-benzyl enanti-
omers are found - one for the esters of aliphatic acids 
(pivalic 4 and butyric 5) and a different one for the best 
inhibitor, (S)-ester of benzoic acid 3 (Figure 5). In 4-S 
and 5-S complexes with BChE, carboxyl oxygen atom 
is pointing away from the catalytic triad and establishes 
strong H-bonds with the Tyr442 side chain hydroxyl 
group and the Trp84 indole amino group (2.9 Å). The 
benzyl moiety is positioned in the hydrophobic region 
near the Trp84 backbone and in the vicinity of the 
Tyr130 side chain. The aromatic ring of the acyl part of 
3-S is also stabilized in this domain. The carboxyl group 
of 3-S has two H-bonds as well: the Tyr130 side chain 
hydroxyl group (2.7 Å) and the Gly117 backbone amide 
(3.3 Å). The additional favourable interactions of two 
aromatic parts of 3-S may be the reason for the best 
inhibitory power of this compound. These results sup-
ported our previous findings based on experimental data 
and quantum-chemical calculations11,12 that (S)-
enantiomers compared to (R)- have stronger interactions 
within the active site of BChE which successfully com-
pete with productive binding leading to the tetrahedral 
intermediate and subsequent hydrolysis. 
 
CONCLUSION 
Differences, similarities and relations among enanti-
omers of selected quinuclidinium esters were studied 
with molecular docking simulations in the active site of 
BChE to determine the origins of observed activity and 
stereoselectivity of the enzyme. The calculated docking 
energies were well correlated with the experimental 
values and supported the experimental data for binding 
affinities of chiral quinuclidinium esters. This study 
demonstrated that flexible ligand docking is appropriate 
and useful tool for studying BChE binding specificity of 
quinuclidinium compounds. 
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